Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
97.7M
-
Shares change
-
+4.48M
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
+$89M
-
Put/Call ratio
-
1.69
-
Number of buys
-
103
-
Number of sells
-
-101
-
Price
-
$19.29
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2025
270 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q1 2025.
Summit Therapeutics Inc. - COM (SMMT) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.7M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (24.4M shares), VANGUARD GROUP INC (11.6M shares), FMR LLC (9.34M shares), BlackRock, Inc. (8.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.56M shares), STATE STREET CORP (4.85M shares), GEODE CAPITAL MANAGEMENT, LLC (3.28M shares), Pictet Asset Management Holding SA (2.66M shares), Balyasny Asset Management L.P. (1.7M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.46M shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.